PTC
RVMD icon

Private Trust Company’s Revolution Medicines RVMD Stock Holding History

Private Trust Company’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Buy
+1,003
New +$147K 0.02% 838
2024
Q4 		– Sell
-102
Closed -$4.63K – 2399
2024
Q3 		$4.63K Buy
+102
New +$4.44K ﹤0.01% 1974

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Private Trust Company's RVMD Position: Q2 2026 in Review

Private Trust Company opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,003 shares worth $188K. The stake represents 0.02% of the portfolio and ranks #838 among its holdings. This is a return to the name: Private Trust Company previously reported a position in RVMD as recently as Q3 2024.

Private Trust Company first reported a position in RVMD in Q3 2024 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Private Trust Company held 1,003 shares of Revolution Medicines worth $188K as of Q2 2026.
  • Revolution Medicines was a new Private Trust Company position in Q2 2026.
  • Revolution Medicines made up 0.02% of Private Trust Company's portfolio in Q2 2026, its #838 holding.
  • Private Trust Company first reported a position in Revolution Medicines in Q3 2024 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.